Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,085
archived clinical trials in
Cervical Cancer

Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
331
mi
from 43215
Nashville, TN
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
331
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
914
mi
from 43215
Dallas, TX
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
914
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
335
mi
from 43215
Milwaukee, WI
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
335
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
1659
mi
from 43215
Phoenix, AZ
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
1659
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
1958
mi
from 43215
Orange, CA
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
1958
mi
from 43215
Orange, CA
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
2107
mi
from 43215
San Francisco, CA
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
2107
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
662
mi
from 43215
Tallahassee, FL
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
662
mi
from 43215
Tallahassee, FL
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
288
mi
from 43215
Park Ridge, IL
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
288
mi
from 43215
Park Ridge, IL
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
476
mi
from 43215
Hackensack, NJ
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
476
mi
from 43215
Hackensack, NJ
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
98
mi
from 43215
Cincinnati, OH
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
8
mi
from 43215
Hilliard, OH
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
8
mi
from 43215
Hilliard, OH
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
358
mi
from 43215
Greenville, SC
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
358
mi
from 43215
Greenville, SC
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
993
mi
from 43215
Galveston, TX
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
993
mi
from 43215
Galveston, TX
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
991
mi
from 43215
Houston, TX
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
468
mi
from 43215
Newark, NJ
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
468
mi
from 43215
Newark, NJ
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from 43215
La Rioja,
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from 43215
La Rioja,
Click here to add this to my saved trials
Cervix Image Sharing Protocol (CISP)
Cervix Image Sharing Protocol (CISP)
Status: Enrolling
Updated:  12/31/1969
National Cancer Institute (NCI)
322
mi
from 43215
Bethesda, MD
Cervix Image Sharing Protocol (CISP)
Cervix Image Sharing Protocol (CISP)
Status: Enrolling
Updated: 12/31/1969
National Cancer Institute (NCI)
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer
Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
480
mi
from 43215
New York, NY
Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer
Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma
A Randomized Phase II Trial of Adjuvant Nivolumab or Expectant Observation Following Neoadjuvant Ipilimumab Plus Nivolumab and Surgical Resection of High-Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma
Status: Enrolling
Updated:  12/31/1969
Alliance for Clinical Trials in Oncology
641
mi
from 43215
Boston, MA
Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma
A Randomized Phase II Trial of Adjuvant Nivolumab or Expectant Observation Following Neoadjuvant Ipilimumab Plus Nivolumab and Surgical Resection of High-Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma
Status: Enrolling
Updated: 12/31/1969
Alliance for Clinical Trials in Oncology
641
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated:  12/31/1969
Research Center
355
mi
from 43215
Chapel Hill, NC
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated: 12/31/1969
Research Center
355
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated:  12/31/1969
Research Center
307
mi
from 43215
Winston-Salem, NC
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated: 12/31/1969
Research Center
307
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated:  12/31/1969
Research Center
937
mi
from 43215
Lake Worth, FL
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated: 12/31/1969
Research Center
937
mi
from 43215
Lake Worth, FL
Click here to add this to my saved trials
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated:  12/31/1969
Research Center
1508
mi
from 43215
Idaho Falls, ID
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated: 12/31/1969
Research Center
1508
mi
from 43215
Idaho Falls, ID
Click here to add this to my saved trials
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated:  12/31/1969
Research Center
1975
mi
from 43215
Los Angeles, CA
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated: 12/31/1969
Research Center
1975
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated:  12/31/1969
Research Center
423
mi
from 43215
Norfolk, VA
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated: 12/31/1969
Research Center
423
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated:  12/31/1969
Research Center
mi
from 43215
South Brisbane,
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated: 12/31/1969
Research Center
mi
from 43215
South Brisbane,
Click here to add this to my saved trials
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Patients Diagnosed With Advanced Malignancy or Myelodysplasia, Tested by Standardized Sequencing, and Treated by Physician-Determined Care Plan: A CureOne Observational Registry (N1)
Status: Enrolling
Updated:  12/31/1969
Teton Cancer Institute
1505
mi
from 43215
Idaho Falls, ID
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Patients Diagnosed With Advanced Malignancy or Myelodysplasia, Tested by Standardized Sequencing, and Treated by Physician-Determined Care Plan: A CureOne Observational Registry (N1)
Status: Enrolling
Updated: 12/31/1969
Teton Cancer Institute
1505
mi
from 43215
Idaho Falls, ID
Click here to add this to my saved trials
Fractional CO2 Laser Therapy for Survivors of Breast Malignancies
Fractional CO2 Laser Therapy for Survivors of Breast Malignancies
Status: Enrolling
Updated:  12/31/1969
Ohio State University Comprehensive Cancer Center
2
mi
from 43215
Columbus, OH
Fractional CO2 Laser Therapy for Survivors of Breast Malignancies
Fractional CO2 Laser Therapy for Survivors of Breast Malignancies
Status: Enrolling
Updated: 12/31/1969
Ohio State University Comprehensive Cancer Center
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
A Phase I/II Clinical Trial of pNGVL4a-Sig/E7 (Detox)/HSP70 for the Treatment of Patients With HPV 16+ Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)
Status: Enrolling
Updated:  12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
345
mi
from 43215
Baltimore, MD
Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
A Phase I/II Clinical Trial of pNGVL4a-Sig/E7 (Detox)/HSP70 for the Treatment of Patients With HPV 16+ Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)
Status: Enrolling
Updated: 12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
345
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis
Prospective Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis Who Are Not Well Controlled With, or Intolerant of, Topical or Systemic Corticosteroids
Status: Enrolling
Updated:  12/31/1969
Washington University in St. Louis
398
mi
from 43215
Saint Louis, MO
Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis
Prospective Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis Who Are Not Well Controlled With, or Intolerant of, Topical or Systemic Corticosteroids
Status: Enrolling
Updated: 12/31/1969
Washington University in St. Louis
398
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Scale Down for Endometrial Cancer
Scale Down: A Randomized, Controlled Weight Management Intervention for Women With Endometrial Cancer
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
397
mi
from 43215
Saint Louis, MO
Scale Down for Endometrial Cancer
Scale Down: A Randomized, Controlled Weight Management Intervention for Women With Endometrial Cancer
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
397
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer
A Phase II Evaluation of Ixabepilone (BMS-247550) [NCI-Supplied Agent, NSC #710428]) in the Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Gynecologic Oncology Group
416
mi
from 43215
Philadelphia, PA
Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer
A Phase II Evaluation of Ixabepilone (BMS-247550) [NCI-Supplied Agent, NSC #710428]) in the Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Gynecologic Oncology Group
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients
Prospective Open Label Study of H.P. Acthar Gel Injection in Patients With Active Non-Infectious Uveitis With Associated Glaucoma Thus High Frequency Regional Corticosteroid and Oral Corticosteroids Cause Intolerable Side-Effects
Status: Enrolling
Updated:  12/31/1969
Tampa Bay Uveitis Center
838
mi
from 43215
Saint Petersburg, FL
Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients
Prospective Open Label Study of H.P. Acthar Gel Injection in Patients With Active Non-Infectious Uveitis With Associated Glaucoma Thus High Frequency Regional Corticosteroid and Oral Corticosteroids Cause Intolerable Side-Effects
Status: Enrolling
Updated: 12/31/1969
Tampa Bay Uveitis Center
838
mi
from 43215
Saint Petersburg, FL
Click here to add this to my saved trials
Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer
The Validity of Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer (EC)
Status: Enrolling
Updated:  12/31/1969
University of Miami
992
mi
from 43215
Miami, FL
Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer
The Validity of Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer (EC)
Status: Enrolling
Updated: 12/31/1969
University of Miami
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Physical Activities by Technology Help (PATH)
Novel Individualized Intervention for Behavioral Change Among High-Risk Group Cancer Survivors : Physical Activities by Technology Help (PATH)
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Bloomberg School of Public Health
346
mi
from 43215
Baltimore, MD
Physical Activities by Technology Help (PATH)
Novel Individualized Intervention for Behavioral Change Among High-Risk Group Cancer Survivors : Physical Activities by Technology Help (PATH)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Bloomberg School of Public Health
346
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women
HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women: A Pilot Study
Status: Enrolling
Updated:  12/31/1969
University of Miami
992
mi
from 43215
Miami, FL
HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women
HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
University of Miami
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Pharmacokinetics and Safety of Vilaprisan in Renal Impairment
An Open-label, Single-dose Study to Evaluate the Pharmacokinetics and Safety of Vilaprisan in Subjects With Decreased Renal Function in Comparison With Matched Subjects With Normal Renal Function
Status: Enrolling
Updated:  12/31/1969
Clinical Pharmacology of Miami
984
mi
from 43215
Miami, FL
Pharmacokinetics and Safety of Vilaprisan in Renal Impairment
An Open-label, Single-dose Study to Evaluate the Pharmacokinetics and Safety of Vilaprisan in Subjects With Decreased Renal Function in Comparison With Matched Subjects With Normal Renal Function
Status: Enrolling
Updated: 12/31/1969
Clinical Pharmacology of Miami
984
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Pharmacokinetics and Safety of Vilaprisan in Renal Impairment
An Open-label, Single-dose Study to Evaluate the Pharmacokinetics and Safety of Vilaprisan in Subjects With Decreased Renal Function in Comparison With Matched Subjects With Normal Renal Function
Status: Enrolling
Updated:  12/31/1969
Orlando Clinical Research Center
798
mi
from 43215
Orlando, FL
Pharmacokinetics and Safety of Vilaprisan in Renal Impairment
An Open-label, Single-dose Study to Evaluate the Pharmacokinetics and Safety of Vilaprisan in Subjects With Decreased Renal Function in Comparison With Matched Subjects With Normal Renal Function
Status: Enrolling
Updated: 12/31/1969
Orlando Clinical Research Center
798
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer
Caloric Restriction for Oncology Research: Pre-operative Caloric Restriction Prior to Definitive Oncologic Surgery
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University
416
mi
from 43215
Philadelphia, PA
Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer
Caloric Restriction for Oncology Research: Pre-operative Caloric Restriction Prior to Definitive Oncologic Surgery
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated:  12/31/1969
Radnet Management
1983
mi
from 43215
Los Angeles, CA
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated: 12/31/1969
Radnet Management
1983
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated:  12/31/1969
University MRI
953
mi
from 43215
Boca Raton, FL
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated: 12/31/1969
University MRI
953
mi
from 43215
Boca Raton, FL
Click here to add this to my saved trials
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated:  12/31/1969
Lahey Clinic
638
mi
from 43215
Burlington, MA
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated: 12/31/1969
Lahey Clinic
638
mi
from 43215
Burlington, MA
Click here to add this to my saved trials
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated:  12/31/1969
Virtua
451
mi
from 43215
Voorhees, NJ
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated: 12/31/1969
Virtua
451
mi
from 43215
Voorhees, NJ
Click here to add this to my saved trials
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated:  12/31/1969
North Texas Uterine Fibroid Institute
913
mi
from 43215
Plano, TX
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated: 12/31/1969
North Texas Uterine Fibroid Institute
913
mi
from 43215
Plano, TX
Click here to add this to my saved trials
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
A Clinical Study To Evaluate the Safety and Efficacy of MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Techniques
Status: Enrolling
Updated:  12/31/1969
The University of California, San Diego
1953
mi
from 43215
La Jolla, CA
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
A Clinical Study To Evaluate the Safety and Efficacy of MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Techniques
Status: Enrolling
Updated: 12/31/1969
The University of California, San Diego
1953
mi
from 43215
La Jolla, CA
Click here to add this to my saved trials
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
A Clinical Study To Evaluate the Safety and Efficacy of MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Techniques
Status: Enrolling
Updated:  12/31/1969
Lahey Clinic
638
mi
from 43215
Burlington, MA
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
A Clinical Study To Evaluate the Safety and Efficacy of MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Techniques
Status: Enrolling
Updated: 12/31/1969
Lahey Clinic
638
mi
from 43215
Burlington, MA
Click here to add this to my saved trials
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
A Clinical Study To Evaluate the Safety and Efficacy of MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Techniques
Status: Enrolling
Updated:  12/31/1969
KNI
208
mi
from 43215
Kalamazoo, MI
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
A Clinical Study To Evaluate the Safety and Efficacy of MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Techniques
Status: Enrolling
Updated: 12/31/1969
KNI
208
mi
from 43215
Kalamazoo, MI
Click here to add this to my saved trials
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
A Clinical Study To Evaluate the Safety and Efficacy of MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Techniques
Status: Enrolling
Updated:  12/31/1969
Cornell Vascular
479
mi
from 43215
New York, NY
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
A Clinical Study To Evaluate the Safety and Efficacy of MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Techniques
Status: Enrolling
Updated: 12/31/1969
Cornell Vascular
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
A Clinical Study To Evaluate the Safety and Efficacy of MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Techniques
Status: Enrolling
Updated:  12/31/1969
Toronto General Hospital
323
mi
from 43215
Toronto,
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
A Clinical Study To Evaluate the Safety and Efficacy of MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Techniques
Status: Enrolling
Updated: 12/31/1969
Toronto General Hospital
323
mi
from 43215
Toronto,
Click here to add this to my saved trials